A detailed history of Black Rock Inc. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Black Rock Inc. holds 17,684 shares of HCM stock, worth $252,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,684
Previous 17,349 1.93%
Holding current value
$252,881
Previous $291,000 3.78%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$16.36 - $21.78 $5,480 - $7,296
335 Added 1.93%
17,684 $302,000
Q1 2024

May 10, 2024

SELL
$12.08 - $18.56 $74,594 - $114,607
-6,175 Reduced 26.25%
17,349 $291,000
Q4 2023

Feb 13, 2024

SELL
$16.25 - $20.23 $225,225 - $280,387
-13,860 Reduced 37.07%
23,524 $426,000
Q3 2023

Nov 13, 2023

SELL
$11.85 - $16.95 $731,784 - $1.05 Million
-61,754 Reduced 62.29%
37,384 $633,000
Q2 2023

Aug 11, 2023

SELL
$10.78 - $17.73 $899,170 - $1.48 Million
-83,411 Reduced 45.69%
99,138 $1.19 Million
Q1 2023

May 12, 2023

BUY
$13.02 - $19.87 $418,723 - $639,019
32,160 Added 21.38%
182,549 $2.38 Million
Q4 2022

Feb 13, 2023

SELL
$7.65 - $15.51 $27.6 Million - $55.9 Million
-3,601,394 Reduced 95.99%
150,389 $2.22 Million
Q3 2022

Nov 14, 2022

SELL
$8.63 - $15.52 $609,139 - $1.1 Million
-70,584 Reduced 1.85%
3,751,783 $33.2 Million
Q2 2022

Aug 12, 2022

BUY
$8.59 - $20.77 $2.63 Million - $6.35 Million
305,782 Added 8.7%
3,822,367 $48.3 Million
Q1 2022

May 12, 2022

BUY
$15.52 - $35.65 $1.92 Million - $4.4 Million
123,396 Added 3.64%
3,516,585 $66.5 Million
Q4 2021

Feb 10, 2022

SELL
$28.89 - $35.33 $2.01 Million - $2.46 Million
-69,586 Reduced 2.01%
3,393,189 $119 Million
Q3 2021

Nov 09, 2021

BUY
$35.66 - $42.94 $16 Million - $19.3 Million
448,350 Added 14.87%
3,462,775 $127 Million
Q2 2021

Aug 11, 2021

BUY
$23.7 - $39.27 $71.4 Million - $118 Million
3,014,425 New
3,014,425 $118 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.